Axonics, Inc. (AXNX)

Axonics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	387.14	366.38	273.7	180.29	111.54	13.82
Revenue Growth (YoY)	30.82%	33.86%	51.81%	61.64%	707.05%	1854.74%
Cost of Revenue	95.83	91.83	76.04	64.57	44.44	6.49
Gross Profit	291.31	274.55	197.67	115.72	67.09	7.33
Selling, General & Admin	251.79	235.32	196.26	135.83	91.68	67.75
Research & Development	37.89	34.89	34.41	37.3	29.06	20.07
Other Operating Expenses	32.5	30.41	31.94	14.4	0.12	0.12
Operating Expenses	322.18	300.61	262.61	187.53	120.85	87.93
Operating Income	-30.87	-26.06	-64.95	-71.81	-53.76	-80.6
Interest Expense / Income	0	-0.62	2.43	7.43	1.87	2.31
Other Expense / Income	-16.92	-16.69	-5.06	0.05	-0.72	-2.97
Pretax Income	-13.95	-8.74	-62.32	-79.29	-54.91	-79.93
Income Tax	2	-2.66	-2.62	0.78	0	0
Net Income	-15.95	-6.09	-59.7	-80.07	-54.92	-79.94
Shares Outstanding (Basic)	51	49	47	43	37	29
Shares Outstanding (Diluted)	51	49	47	43	37	29
Shares Change	4.84%	5.13%	8.39%	16.47%	29.45%	308.23%
EPS (Basic)	-0.31	-0.12	-1.28	-1.86	-1.48	-2.80
EPS (Diluted)	-0.31	-0.12	-1.28	-1.86	-1.48	-2.80
Free Cash Flow	-16.29	-5.57	0.97	-49.57	-86.68	-84.79
Free Cash Flow Per Share	-0.32	-0.11	0.02	-1.15	-2.34	-2.97
Gross Margin	75.25%	74.94%	72.22%	64.18%	60.15%	53.04%
Operating Margin	-7.97%	-7.11%	-23.73%	-39.83%	-48.20%	-583.21%
Profit Margin	-4.12%	-1.66%	-21.81%	-44.41%	-49.24%	-578.40%
Free Cash Flow Margin	-4.21%	-1.52%	0.35%	-27.49%	-77.72%	-613.55%
EBITDA	-1.1	3.12	-48.16	-62.73	-51.3	-76.43
EBITDA Margin	-0.28%	0.85%	-17.60%	-34.80%	-45.99%	-553.07%
Depreciation & Amortization	12.86	12.49	11.72	9.13	1.74	1.19
EBIT	-13.95	-9.37	-59.88	-71.86	-53.04	-77.63
EBIT Margin	-3.60%	-2.56%	-21.88%	-39.86%	-47.55%	-561.69%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).